Trends in antimicrobial resistance in Shigella species in Karachi, Pakistan.

作者: Erum Khan , Kausar Jabeen , Muslima Ejaz , Jaweriah Siddiqui , Muhammad Farrukh Shezad

DOI: 10.3855/JIDC.500

关键词:

摘要: Background: Shigellosis is a common cause of morbidity, especially in the very young and old, developing countries.  The disease treated with antibiotics. Surveillance antimicrobial resistance trends essential owing to global emergence resistance. Methodology: study involved 1,573 isolates Shigella species (1996-2007) that were analyzed for Results: majority specimens (1046; 66.5%) from pediatric population, these 887 (84.8%) under 5 years age (p = 0.001). S. flexineri was most frequent (54.5%) isolated. Isolation sonnei increased 15.4 % (1996) 39% (2007) Although none found sensitive all antibiotics tested, 58% (n =9 07) resistant ampicillin 85% 1,338) trimethoprim-sulfamethoxazole (TMP-SMX). Out total 198 (12.6%) nalidixic acid isolates, 6 (3.0%) also ofloxacin. Overall 1.7 ofloxacin, 2.4% ceftriaxone 2.3% combination ampicillin, TMP-SMX. Conclusion: Ofloxacin still an effective drug treatment acute shigellosis Pakistan. Emergence may have grave implications severe patients.

参考文章(14)
Kuo ChenYen Kuo ChenYen, Su LinHui Su LinHui, J Perera, C Carlos, Tan BanHock Tan BanHock, G Kumarasinghe, T So, Pham Hung Van Pham Hung Van, A Chongthaleong, Song JaeHoon Song JaeHoon, Chiu ChengHsun Chiu ChengHsun, Antimicrobial susceptibility of Shigella isolates in eight Asian countries, 2001-2004 Journal of Microbiology Immunology and Infection. ,vol. 41, pp. 107- 111 ,(2008)
Md Sirajul Islam, MA Hossain, SI Khan, MNH Khan, RB Sack, M John Albert, A Huq, RR Colwell, None, Survival of Shigella dysenteriae type 1 on fomites. Journal of Health Population and Nutrition. ,vol. 19, pp. 177- 182 ,(2001) , 10.3329/JHPN.V19I3.90
Abdullah H. Baqui, Shams El Arifeen, David A. Sack, Shereen Shoma, A. K. Siddique, G. B. Nair, Mahbubur Rahman, Harunur Rashid, Increasing Spectrum in Antimicrobial Resistance of Shigella Isolates in Bangladesh: Resistance to Azithromycin and Ceftriaxone and Decreased Susceptibility to Ciprofloxacin Journal of Health Population and Nutrition. ,vol. 25, pp. 158- 167 ,(2007) , 10.3329/JHPN.V25I2.655
O. S. Levine, M. M. Levine, Houseflies (Musca domestica) as mechanical vectors of shigellosis. Clinical Infectious Diseases. ,vol. 13, pp. 688- 696 ,(1991) , 10.1093/CLINIDS/13.4.688
V. Vasilev, R. Japheth, R. Yishai, N. Andorn, L. Valinsky, S. Navon-Venezia, I. Chmelnitsky, Y. Carmeli, D. Cohen, Extended-spectrum β-lactamase-producing Shigella strains in Israel, 2000–2004 European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 26, pp. 189- 194 ,(2007) , 10.1007/S10096-007-0263-Y
MICHAEL L. BENNISH, MOHAMMED A. SALAM, Rethinking options for the treatment of shigellosis. Journal of Antimicrobial Chemotherapy. ,vol. 30, pp. 243- 247 ,(1992) , 10.1093/JAC/30.3.243
J. P. Winickoff, M. M. Levine, J. D. Clemens, B. Ivanoff, P. J. Sansonetti, G. K. Adak, D. L. Swerdlow, K. L. Kotloff, Global Burden of Shigella Infections: Implications for Vaccine Development and Implementation of Control Strategies Bulletin of The World Health Organization. ,vol. 77, pp. 651- 666 ,(1999)
MARK L. ROSENBERG, JACK B. WEISSMAN, EUGENE J. GANGAROSA, L. BARTH RELLER, R. PALMER BEASLEY, SHIGELLOSIS IN THE UNITED STATES: FIVE-YEAR REVIEW OF NATIONWIDE SURVEILLANCE, 1964–1968 American Journal of Epidemiology. ,vol. 91, pp. 543- 551 ,(1970) , 10.1093/OXFORDJOURNALS.AJE.A112328
T. Cheasty, M. Day, E.J. Threlfall, Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy Clinical Microbiology and Infection. ,vol. 10, pp. 1033- 1035 ,(2004) , 10.1111/J.1469-0691.2004.00982.X
Sumathi Sivapalasingam, Jennifer M. Nelson, Kevin Joyce, Mike Hoekstra, Frederick J. Angulo, Eric D. Mintz, High Prevalence of Antimicrobial Resistance among Shigella Isolates in the United States Tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002 Antimicrobial Agents and Chemotherapy. ,vol. 50, pp. 49- 54 ,(2006) , 10.1128/AAC.50.1.49-54.2006